Nanotechnology in Medical Applications: The Global Market

NEW YORK, Oct. 12, 2017 /PRNewswire/ -- The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017.



Read the full report: https://www.reportlinker.com/p0170502


• Anticancers as a segment is projected to grow at a CAGR of 12.3% from 2017 to 2022, and should reach $84.4 billion by 2022 from $47.3 billion in 2017.
• CNS products as a segment is projected to grow at a CAGR of 18.2% and should reach $76.0 billion by 2022 from $32.9 billion in 2017.

Chapter 1: Introduction
Study Goals and Objectives
The purpose of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription drug products incorporating nanotechnology features. Important trends are identified, and sales forecasts by product categories and major country markets are provided through 2014; these are based on industry sources and considered assessments of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the nanomedicine-related drug market. The wider economic environment is also taken into account.

The report examines strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market.

Reasons for Doing the Study
Nanomedicine is already an established market. Unlike some other potential applications of nanotechnology, which are still largely experimental, nanomedicine has already produced some significant products in which the nano dimension has made a significant contribution to product effectiveness. Now that aspects of the nanomedicine market are established, it is appropriate to review the technology, see its practical applications so far, evaluate the participating companies and look to its future.

Scope of Report
This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity.

Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-
inflammatories.

Market Analyses and Forecasts
Market figures are based on revenues at the manufacturer level and are projected at the 2017-dollar value without attempting to predict the effect of inflation or deflation.
The quantified therapeutic categories forecast include cancer, central nervous system (CNS) diseases, infections and cardiovascular conditions. The country markets analyzed are the U.S., Japan, Germany, France, the U.K., Italy and Spain.

Methodology
Primary research included interviews with leading individuals in nanomedicine companies and industry associations. Principal sources of published data include company annual reports and SEC filings as well as government and industry publications. Secondary sources consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts were pooled from a range of sources, critically assessed by BCC Research.

Intended Audience
This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. However, it is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplace in which they are operating.

Information Sources
Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also mined, as well as publications of relevant trade associations.

Global Market for Nanomedicals, by Therapeutic Area
Anticancers
CNS products
Anti-infectives
Cardiovasculars
Anti-inflammatories
Others

Chapter 2: Summary and Highlights
Nanomedicine Market

Nano-enabled medical products began appearing on the market over a decade ago, and some have become best-sellers in their therapeutic categories. The principal areas in which nanomedical products have made an impact are cancer, CNS diseases, cardiovascular disease and infection control. The Summary Table gives estimates of the historical and current markets for these nanomedicine areas with a forecast through 2022.

The U.S. market is by far the largest in the global nanomedicine market and is set to continue to dominate the world marketplace; however, other national markets are expected to increase their shares over the next five years.

Read the full report: https://www.reportlinker.com/p0170502

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

https://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com